News | 2023.06.14
From June 26 to 29, 2023, The Hellenic Pasteur Institute, member of the Pasteur Network, is organizing a workshop on technology transfer in biological sciences and public health. Targeting young researchers from all over the world, it will offer an opportunity to immerse in the innovation ecosystem. Some members of Institut Pasteur's Technology Transfer and Industrial Partnership Department (...
News | 2019.11.22
The Activity Report for the Pasteur Microbes and Health Carnot Institute has now been published. It looks back at the main activities carried out in 2018, in synergy with the Institut Pasteur's Research Applications and Industrial Relations Department (DARRI). These activities are in line with the Institut Pasteur's 2019-2023 Strategic Plan.The Pasteur Microbes and Health (Pasteur MS) Carnot...
Article | 2016.12.02
Innovation development and technology transfer are promoted by the Institut Pasteur through its multidisciplinary and transversal approach to research.
News | 2021.05.06
The Institut Pasteur has recently signed an exclusive worldwide license agreement with the new biotech start-up SpikImm SAS, created by Truffle Capital, for the development of anti-SARS-CoV-2 (Covid-19) monoclonal antibodies for therapeutic and diagnostic use.Monoclonal antibody therapy is one of the most innovative ways currently available to treat Covid-19 patients and prevent severe forms of...
News | 2022.07.19
The first Pasteur Innov Day, held on campus on July 7 and organized by the Department of Technology, the Technology Transfer and Industrial Partnership Department (DARRI) and the management team at the institut Pasteur Microbes & Santé, was attended by around a hundred industrial and academic partners. "There is no innovation without technology" was the motto of a day that provided plenty of...
News | 2025.04.29
The Institut Pasteur, a Carnot institute since 2007, and ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, recently signed a licensing agreement for the integration of the innovative HPV RNA sequencing technology into ABL Diagnostics solutions, which will produce and market the test.HPV RNA-Seq is a cutting-edge diagnostic method that enhances the detection and typing of high-...
News | 2019.06.04
The aim of the Icypro project is to transfer the expertise and advanced bioimage analysis solutions developed at the Institut Pasteur to fields where they will have a real impact for patients, such as diagnostics, medtech and drug discovery. On May 21, 2019, all the Icypro project partners and funders gathered at the Institut Pasteur for the official project launch.Winner of the 2018 SESAME...
Article | 2025.03.10
Some situations require closer monitoring, either when requested by a funder or because they represent a specific risk (for example a health or environmental risk or a conflict of interest). In these cases, the Institut Pasteur supports the teams concerned via two permanent operational groups: the Dual Use Liaison Group (DULG) and the Conflict of Interest Review Board (GELI). An ad hoc committee...
Document de presse | 2022.12.13
In connection with the bicentenary of Louis Pasteur’s birth, a conference entitled "Epidemics, pandemics: a never-ending story?" was held on Wednesday December 7 at the Institut Pasteur under the high patronage of the French President, Emmanuel Macron. The conference marked the end of a year of events highlighting not only the importance of research in tackling infectious diseases, but also the...
News | 2024.07.03
On June 25, 2024, the Institut Pasteur hosted the second edition of Pasteur Innov'Day. The goal was to demonstrate the potential of the Institut Pasteur's research and innovation continuum to industry players in the health sector. The event was attended by almost 150 partners (startups, SMEs, major pharmaceutical corporations, investors, and other innovation stakeholders) as well as many Institut...